Our finding of a pks + E coli genotoxin signature in an LFS patient’s colorectal cancer is intriguing and suggests an opportunity for future studies to explore this as a mechanism by which LFS patients may develop such tumors. The gene discussed is ARAF; the disease is colorectal cancer.